Your browser doesn't support javascript.
loading
Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis.
Ueda Oshima, Masumi; Storer, Barry E; Qiu, Huiying; Chauncey, Thomas; Asch, Julie; Boyer, Michael W; Giaccone, Luisa; Flowers, Mary; Mielcarek, Marco; Storb, Rainer; Maloney, David G; Sandmaier, Brenda M.
Afiliação
  • Ueda Oshima M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: mueda@fredhutch.org.
  • Storer BE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Qiu H; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Chauncey T; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; VA Puget Sound Health Care System, Seattle, Washington.
  • Asch J; Intermountain Healthcare, Salt Lake City, Utah.
  • Boyer MW; University of Utah, Salt Lake City, Utah.
  • Giaccone L; Torino University, Torino, Italy.
  • Flowers M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Mielcarek M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Storb R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.
Transplant Cell Ther ; 27(2): 163.e1-163.e7, 2021 02.
Article em En | MEDLINE | ID: mdl-33830025

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2021 Tipo de documento: Article